| Literature DB >> 35361087 |
Mustafa Onur Karaca, Emre Anıl Özbek1, Mustafa Özyıldıran, Abdullah Merter, Kerem Başarır, Hüseyin Yusuf Yıldız, Yener Sağlık.
Abstract
OBJECTIVES: This study aims to investigate the factors that may be associated with surgical site infection and mortality in pelvic resection surgeries. PATIENTS AND METHODS: A total of 68 patients (40 males, 28 females; mean age: 43±16.2 years; range, 11 to 70 years) who underwent internal or external hemipelvectomy between January 2010 and January 2020 were retrospectively analyzed. We reviewed data concerning histopathological diagnosis, surgical technique, pelvic resection type, tumor size, postoperative infection, duration of follow-up, and mortality.Entities:
Mesh:
Year: 2022 PMID: 35361087 PMCID: PMC9057530 DOI: 10.52312/jdrs.2022.560
Source DB: PubMed Journal: Jt Dis Relat Surg ISSN: 2687-4792
Patient characteristics and surgical data
| Outcomes | |||
| Variables | n | % | Mean±SD |
| Sex | |||
| Male | 40 | 58.8 | |
| Female | 28 | 41.2 | |
| Mean age at diagnosis | 43.0±16.2 | ||
| Mean follow up (months) | 45.5±42.2 | ||
| Surgical technique | |||
| External hemipelvectomy | 29 | 42.6 | |
| Internal hemipelvectomy | 39 | 57.4 | |
| With reconstruction | 14 | 20.6 | |
| Without reconstruction | 25 | 36.8 | |
| Pelvic resection types in internal hemipelvectomies | |||
| Type I | 9 | 23.1 | |
| Type II | 2 | 5.1 | |
| Type III | 9 | 23.1 | |
| Type IV | 1 | 2.6 | |
| Type I-IV | 2 | 5.1 | |
| Type I-II | 8 | 20.5 | |
| Type II-III | 6 | 15.4 | |
| Type I-II-III | 2 | 5.1 | |
| Treatments other than surgery | |||
| Chemotherapy | 19 | 27.9 | |
| Radiotherapy | 3 | 7.7 | |
| Radiotherapy + chemotherapy | 10 | 25.6 | |
| SD: Standard deviation. | |||
Histopathological type and frequency of primary (non-metastatica) malignant pelvic tumors in 61 patients, by Enneking Stageb; January, 2010 to January, 2020
| Malignant pelvic tumors Histopathological types | Enneking stage | Totals | ||||
| IA | IB | IIA | IIB | III | ||
| Chondrosarcoma | 3 | 12 | 4 | 6 | - | 25 |
| Osteosarcoma | - | - | 2 | 9 | 2 | 13 |
| Ewing sarcoma | - | - | 2 | 5 | 1 | 8 |
| Malignant mesenchymal tumor | - | - | - | 4 | 1 | 5 |
| Squamous cell carcinoma | - | - | - | 1 | 3 | 4 |
| Pleomorphic sarcoma | - | - | - | 1 | 1 | 2 |
| Liposarcoma | - | - | - | 2 | - | 2 |
| Fibrosarcoma | - | - | - | 1 | - | 1 |
| Lymphangiosarcoma | - | - | - | 1 | - | 1 |
| Totals | 3 | 12 | 8 | 30 | 8 | 61 |
| a Of 68 total patients, 61 had primary malignant pelvic tumors, and 2 had malignant pelvic tumors that were metastases from other primary sites. Other 5 patients underwent internal/external hemipelvectomy for nonmalignant reasons. Of these 5 patients; 2 had giant cell tumor, 2 had pelvic hydatid cyst and 1 had aneurysmal bone cyst. | ||||||
Surgical procedure types and postoperative infection status of pelvic resection surgeries, at mean follow-up 45.5 (±42.2) months; January, 2010 to January, 2020
| Infection | ||||||||
| Superficial | Deep | Without infection | ||||||
| Surgical procedures | n | % | n | % | n | % | Total | |
| External hemipelvectomy | 8 | 27.6 | 12 | 41.4 | 9 | 31.0 | 29 | |
| Internal hemipelvectomy | 7 | 17.9 | 7 | 17.9 | 25 | 64.1 | 39 | 0.02 |
| Totals | 15 | 22.1 | 19 | 27.9 | 34 | 50.0 | 68 | |
| aThe Chi Square test was used to assess the potential differences between the external and internal hemipelvectomy surgeries. Differences were considered statistically significant for p value<0.05. | ||||||||
Postoperative infection status of the 39 patients treated with internal hemipelvectomy surgery at mean follow-up 45.5 (±42.2) months; January, 2010 to January, 2020
| Infection | Total | |||||||
| Superficial | Deep | Without infection | ||||||
| n | % | n | % | n | % | |||
| Reconstruction status | ||||||||
| Internal hemipelvectomy with reconstruction | 3 | 21.4 | 3 | 21.4 | 8 | 57.1 | 14 | 0.53 |
| Internal hemipelvectomy without reconstruction | 4 | 16.0 | 4 | 16.0 | 17 | 68.0 | 25 | |
| Tumor sizeb | ||||||||
| >10 cm | 6 | 20.7 | 5 | 17.2 | 18 | 62.1 | 29 | 0.52 |
| <10 cm | 1 | 10.0 | 2 | 20.0 | 7 | 70.0 | 10 | |
| a The Chi Square test was used to assess the potential differences according to reconstruction status and tumor size. Differences were considered statistically non-significant for p value>0.05 | ||||||||
Postoperative infection status of the 39 patients treated with internal hemipelvectomy surgery according to pelvic resection typesb at mean follow-up 45.5 (±42.2) months; January, 2010 to January, 2020
| Infection | ||||||
| Internal hemipelvectomy | Superficial or deep infection | Without infection | ||||
| Pelvic resection type | n | % | n | % | Total | pa |
| Type I or Type III | 3 | 16.7 | 15 | 83.3 | 18 | |
| Type II or Type I+II or Type II+III or Type I+II+III or | 11 | 52.4 | 10 | 47.6 | 21 | 0.02 |
| Type I+IV | ||||||
| a The chi-square test was used to assess the potential differences according to reconstruction status and tumor size. Differences were considered statistically non-significant for p value >0.05. | ||||||